HGH (Somatropin)
Recombinant human growth hormone — the protein itself, not a peptide that nudges your body to make more. Highest legal-risk compound in this catalog.
HGH is the actual growth hormone protein your pituitary releases — not a peptide that nudges your body to release more. Prescription only in legitimate medicine. Carries the highest legal risk of anything in this space if used non-medically. Most users in this catalog run GH-axis *peptides* (Ipamorelin, CJC, Tesamorelin, Sermorelin) instead, which signal your own body to produce more GH naturally and carry far less regulatory exposure.
Recombinant HGH is the canonical 'not natty' compound. No federation accepts it.
Approved under multiple brand names (Genotropin, Humatrope, Norditropin, Saizen, Omnitrope) for GH deficiency, AIDS wasting, Turner syndrome, short stature in children, idiopathic short stature, SHOX deficiency, and others.
Available as an FDA-approved drug, not a compounded peptide.
Yes — by endocrinologists for the approved indications. Performance use is illegal under the U.S. Anabolic Steroid Control Act.
Pepdex covers HGH for educational reference only. Recombinant HGH is regulated under the U.S. Anabolic Steroid Control Act for non-medical use. The vendor list Pepdex emails to members does not include HGH suppliers. Most users in this space run GH-axis peptides (Ipamorelin, CJC-1295, Tesamorelin, Sermorelin) which are documented in this catalog.
Who it's for
- →People who already have a legitimate medical prescription (GH deficiency, AIDS wasting, short stature)
- →Educational reference — most users in this space run GH-axis peptides instead
What to expect
- Week 1
Water retention, mild joint stiffness, sleep changes.
- Week 4
IGF-1 climbs noticeably. Skin and recovery improvements appear.
- Week 8
Body comp shifts in users training with adequate protein.
Dosing protocol
Medical: 1-3 IU daily. Performance use is illegal under federal law in the US (Anabolic Steroid Control Act).
Stacks well with
Side effects
When NOT to use
- ⚠Active malignancy
- ⚠Active diabetic retinopathy
- ⚠Pregnancy / nursing
- ⚠No legitimate medical indication
Bloodwork to monitor
- • IGF-1
- • Fasting glucose / A1C
- • TSH / fT4
- • ALT/AST
Common mistakes
- • Treating it like a peptide with low oversight — it isn't
- • Underestimating the legal/regulatory risk
- • Stacking with other things that raise insulin resistance
Educational only. User-specific dosing is between you and a qualified provider.